Spotlight
Video

Talazoparib is Effective in Neoadjuvant Setting | Combine PARP-Inhibitors w Immune Checkpoint

Loading........
Description: Hope S. Rugo, MD, FAnnual Meeting, University of California, San Francisco explains Talazoparib is Effective in Neoadjuvant Setting | Combine PARP-Inhibitors w Immune Checkpoint at Annual Meeting 2018
Shared By : Annual-Meeting
Posted on : 06/13/18
Added : 1 year ago
Category : Breast Cancer



Recommended

Nothing found.